Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hims & Hers Health, Inc. - SIC # 5270 -
Ticker
Exchange
SIC #
Website
Latest Ticker
HIMS
New York
5270
www.hims.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hims & Hers Health, Inc.
Hims & Hers Chief Legal Officer Soleil Boughton Sells 6,236 Shares
- Sep 19th, 2026 8:15 am
How FTC Data‑Sharing Complaint And Investor Lawsuits At Hims & Hers Health (HIMS) Have Changed Its Investment Story
- Sep 15th, 2026 8:12 pm
Hims & Hers Health, Inc. (HIMS) Falls More Steeply Than Broader Market: What Investors Need to Know
- Sep 15th, 2026 3:45 pm
Gap Inc. Appoints Kirsten Green to Board of Directors
- Sep 15th, 2026 2:15 pm
HIMS Bulls Should Heed This Historic Chart Signal
- Sep 14th, 2026 1:21 pm
I'm Calling It: Hims & Hers Health Will Soar 56% by the End of 2026
- Sep 13th, 2026 2:35 am
JPMorgan Tweaks Hims & Hers Stock Outlook on Key Risk
- Sep 11th, 2026 3:12 pm
JPMorgan cautious on Hims & Hers on GLP-1 transition risk
- Sep 11th, 2026 7:14 am
Pump.fun Launches Custom Pairs for Tokenized Stocks
- Sep 10th, 2026 12:19 pm
Why Is Hims & Hers Health (HIMS) Down 7.7% Since Last Earnings Report?
- Sep 9th, 2026 9:30 am
Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know
- Sep 8th, 2026 3:45 pm
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
- Sep 8th, 2026 7:00 am
Here's Why Teladoc's Integrated Care Business Deserves More Attention
- Sep 7th, 2026 8:51 am
HIMS Raises 2026 Revenue Outlook as Q2 Sales Rise 38.2% Despite Loss
- Sep 2nd, 2026 12:30 pm
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now
- Sep 2nd, 2026 12:30 pm
PAHC or LMAT: Which Is the Better Value Stock Right Now?
- Sep 2nd, 2026 9:40 am
Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?
- Sep 2nd, 2026 9:30 am
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders
- Sep 2nd, 2026 9:17 am
Charlotte's Web Applauds Congressional Action to Advance Continuing Resolution
- Sep 2nd, 2026 9:07 am
Scroll